"What we have seen is reversal of a gene abnormality.
Among Ashkenazi Jews, 2.5percentt of females and males carry either a BRCA1 or BRCA2 gene abnormality.
Although their specificity for cancer was limited compared with that of genetic markers such as p53, APC, c-met, k-sam and c-erbB-2, immunohistological detection of antigen is much easier than molecular biological analysis of those gene abnormalities, and this is of practical importance.
Analysis of p21 and p27 gene abnormalities in human pituitary adenoma was performed in 28 pituitary adenomas by polymerase chain reaction-single-strand conformational polymorphism.
But isolating and understanding specific gene abnormalities is challenging with diploid cells because they typically have a copy that is normal and serves as a backup.
All of these lead to cell death, gene abnormalities and cancer [4].
Subtype 4 is associated with RAS gene abnormalities.
Hence Mpl gene abnormalities were not detected in AMM patients.
The BRCA2 mutations included eight different gene abnormalities (Table 2).
Gene mutational analysis on all patients will be carried out on all patients and will correlate abnormalities found with clinical phenotype.
